QL9

QL9 (QLSPFPFDL) is a high-affinity alloantigen for the 2C T cell receptor (TCR) .

Product Specifications

CAS Number

[159646-83-0]

UNSPSC

12352209

Target

CD3

Type

Peptides

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/QL9.html

Solubility

10 mM in H2O

Smiles

O=C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(N1[C@@H](CCC1)C(N[C@@H](CC2=CC=CC=C2)C(N3[C@@H](CCC3)C(N[C@@H](CC4=CC=CC=C4)C(N[C@@H](CC(O)=O)C(N[C@@H](CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CCC(N)=O)N

Molecular Formula

C52H74N10O14

Molecular Weight

1063.20

References & Citations

[1]Speir JA, et al. Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes. Immunity. 1998 May;8 (5) :553-62.|[2]Bowerman NA, et al. Different strategies adopted by K (b) and L (d) to generate T cell specificity directed against their respective bound peptides. J Biol Chem. 2009 Nov 20;284 (47) :32551-61.